article thumbnail

Injectable opportunities for CMOs despite internal capacity of big pharma sponsors

Pharmaceutical Technology

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Why do large and mega-cap sponsors outsource?

article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

. White House will make unordered vaccine supply available to other states ( WaPo ). White House set to send vaccines abroad ( Politico ). cases, vaccinations continue to drop as White House sets new inoculation goal ( CNBC ). BD Taps Contract Packager for COVID-19 Test Kits ( MD+DI ).